These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 589727)

  • 21. Glutathione as a scavenger of free hemin. A mechanism of preventing red cell membrane damage.
    Shviro Y; Shaklai N
    Biochem Pharmacol; 1987 Nov; 36(22):3801-7. PubMed ID: 3689422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-specific inhibition of human cytochrome P450-catalyzed reactions by hemin.
    Kim EY; Kim JS; Kim MY; Koh WS; Guengerich FP; Yun CH
    Toxicol Lett; 2004 Nov; 153(2):239-46. PubMed ID: 15451555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rabbit reticulocyte model for the role of hemin-controlled repressor in hypochromic anemias.
    Freedman ML; Rosman J
    J Clin Invest; 1976 Mar; 57(3):594-603. PubMed ID: 2617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catalytic characteristics of CYP3A4: requirement for a phenolic function in ortho hydroxylation of estradiol and mono-O-demethylated methoxychlor.
    Stresser DM; Kupfer D
    Biochemistry; 1997 Feb; 36(8):2203-10. PubMed ID: 9047321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of protein synthesis by hemin: effect of dithiothreitol on the formation and activity of the hemin-controlled translational repressor.
    Gross M
    Biochim Biophys Acta; 1978 Oct; 520(3):642-9. PubMed ID: 718919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of heme on intracellular iron pools during differentiation of Friend erythroleukemia cells.
    Hradilek A; Borová J; Fuchs O; Neuwirt J
    Biochim Biophys Acta; 1981 Dec; 678(3):373-80. PubMed ID: 6947826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axial ligand effect on the rate constant of aromatic hydroxylation by iron(IV)-oxo complexes mimicking cytochrome P450 enzymes.
    Kumar D; Sastry GN; de Visser SP
    J Phys Chem B; 2012 Jan; 116(1):718-30. PubMed ID: 22132821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The release of inorganic fluoride from halothane and halothane metabolites by cytochrome P-450, hemin, and hemoglobin.
    Baker MT; Nelson RM; Van Dyke RA
    Drug Metab Dispos; 1983; 11(4):308-11. PubMed ID: 6137335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A thiolate ligand on a cytochrome P-450 mimic permits the use of simple environmentally benign oxidants for biomimetic steroid hydroxylation in water.
    Fang Z; Breslow R
    Bioorg Med Chem Lett; 2005 Dec; 15(24):5463-6. PubMed ID: 16183271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion of the 2,2,6,6-tetramethylpiperidine moiety to a 2,2-dimethylpyrrolidine by cytochrome P450: evidence for a mechanism involving nitroxide radicals and heme iron.
    Yin W; Mitra K; Stearns RA; Baillie TA; Kumar S
    Biochemistry; 2004 May; 43(18):5455-66. PubMed ID: 15122911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Models and mechanisms of O-O bond activation by cytochrome P450. A critical assessment of the potential role of multiple active intermediates in oxidative catalysis.
    Hlavica P
    Eur J Biochem; 2004 Nov; 271(22):4335-60. PubMed ID: 15560776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How does the axial ligand of cytochrome P450 biomimetics influence the regioselectivity of aliphatic versus aromatic hydroxylation?
    de Visser SP; Tahsini L; Nam W
    Chemistry; 2009; 15(22):5577-87. PubMed ID: 19347895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel exogenous heme-dependent expression of mammalian cytochrome P450 using baculovirus.
    Asseffa A; Smith SJ; Nagata K; Gillette J; Gelboin HV; Gonzalez FJ
    Arch Biochem Biophys; 1989 Nov; 274(2):481-90. PubMed ID: 2679389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible inhibition of cytochrome P450 by nitric oxide.
    Minamiyama Y; Takemura S; Imaoka S; Funae Y; Tanimoto Y; Inoue M
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1479-85. PubMed ID: 9400024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of heme oxygenase: a study with synthetic hemins.
    Frydman RB; Tomaro ML; Buldain G; Awruch J; Díaz L; Frydman B
    Biochemistry; 1981 Sep; 20(18):5177-82. PubMed ID: 6895313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoselectivity of each of the three steps of the heme oxygenase reaction: hemin to meso-hydroxyhemin, meso-hydroxyhemin to verdoheme, and verdoheme to biliverdin.
    Zhang X; Fujii H; Matera KM; Migita CT; Sun D; Sato M; Ikeda-Saito M; Yoshida T
    Biochemistry; 2003 Jun; 42(24):7418-26. PubMed ID: 12809497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aspects of application of cytochrome P-450 and related systems in substrate hydroxylation.
    Mohr P; Scheller F; Renneberg R; Kühn M; Scheler W
    Pharmazie; 1978 Jul; 33(7):415-8. PubMed ID: 31630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the microsomal N-hydroxylation of 2-amino-6-nitrotoluene by a metabolite of methimazole.
    Kedderis GL; Rickert DE
    Biochem Biophys Res Commun; 1983 Jun; 113(2):433-8. PubMed ID: 6870866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of membrane erythrocyte (Ca2+ + Mg2+)-ATPase by hemin.
    Leclerc L; Vasseur C; Bursaux E; Marden M; Poyart C
    Biochim Biophys Acta; 1988 Dec; 946(1):49-56. PubMed ID: 2974727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of substituents in fluorobenzene derivatives on the cytochrome P450-catalyzed hydroxylation at the adjacent ortho aromatic carbon center.
    Koerts J; Velraeds MM; Soffers AE; Vervoort J; Rietjens IM
    Chem Res Toxicol; 1997 Mar; 10(3):279-88. PubMed ID: 9084907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.